ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) shares dropped 3.2% during mid-day trading on Thursday . The company traded as low as $67.94 and last traded at $68.56. Approximately 51,634 shares were traded during mid-day trading, an increase of 37% from the average session volume of 37,809 shares. The stock had previously closed at $70.79.
ALPS Medical Breakthroughs ETF Trading Up 0.8%
The business has a fifty day moving average price of $64.22 and a two-hundred day moving average price of $56.50.
Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF
A number of large investors have recently made changes to their positions in SBIO. Moran Wealth Management LLC grew its position in ALPS Medical Breakthroughs ETF by 39.2% during the first quarter. Moran Wealth Management LLC now owns 29,348 shares of the company’s stock valued at $1,536,000 after purchasing an additional 8,264 shares in the last quarter. Delta Investment Management LLC acquired a new stake in shares of ALPS Medical Breakthroughs ETF during the 4th quarter valued at $6,112,000. Osaic Holdings Inc. grew its holdings in shares of ALPS Medical Breakthroughs ETF by 1,099.0% during the 4th quarter. Osaic Holdings Inc. now owns 7,050 shares of the company’s stock valued at $361,000 after acquiring an additional 6,462 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of ALPS Medical Breakthroughs ETF in the fourth quarter worth $257,000. Finally, Janney Montgomery Scott LLC purchased a new stake in shares of ALPS Medical Breakthroughs ETF during the fourth quarter worth $220,000.
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
Further Reading
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
- Flash in the Pan or Sustained Rally Contender? 3 Momentum Stocks to Watch
- MarketBeat Week in Review – 08/17 – 08/21
- Blueprint for a Boom: SEC Clears the Crypto Runway
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
